A new model for improving how clinical trials are developed and conducted by bringing together academic cancer experts and pharmaceutical companies is being tested by research experts at The University of Texas MD Anderson ...
May 14, 2018
0
2
Scientists have discovered the first leukaemia protective gene that is specific to the male-only Y chromosome. Researchers at the Wellcome Sanger Institute and the University of Cambridge found that this Y-chromosome gene ...
May 7, 2018
0
154
It's time to move beyond the traditional "magic bullet" approach for discovering new drugs and start leveraging the full complexity of Mother Nature, according to Vanderbilt Professor of Chemistry Brian Bachmann and Assistant ...
May 3, 2018
0
13
In March 2017, the U.S. Food and Drug Administration approved ocrelizumab as the first treatment for both relapsing (RMS) and progressive forms of multiple sclerosis (MS), a genetic disease that afflicts approximately 400,000 ...
Apr 26, 2018
0
7
Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow that comprises 1 percent of all new cancer cases and almost 2 percent of cancer deaths in the U.S. The five-year survival rate for the disease is less ...
Apr 25, 2018
0
3
Until recently, scientific research concentrated almost exclusively on the 2 percent of the genome's protein coding regions, virtually ignoring the other 98 percent - a vast universe of non-coding genetic material previously ...
Apr 19, 2018
0
65
When prostate cancer metastasizes to bone, it can become especially dangerous - not only with its action in the bone but, interestingly, with increased aggressiveness of the overall cancer itself. Now, research presented ...
Apr 16, 2018
0
5
The sequencing of 20,000 human genes has produced an immense amount of data that must now be deciphered. Sébastien Lemieux, a bioinformatics specialist at Université de Montréal's Institute for Research in Immunology and ...
Apr 13, 2018
0
16
Wistar researchers have found that soluble antibodies promote tumor progression by inducing accumulation of myeloid-derived suppressor cells (MDSCs) in pre-clinical cancer models. Results were published online in Cancer Immunology ...
Apr 12, 2018
0
3
A drug called dasatinib was found to be safe and effective for children with chronic myeloid leukemia, according to a clinical trial published in the Journal of Clinical Oncology.
Apr 12, 2018
0
3
